Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	36-482-hyaluronoglucosaminidase ph20 (rhuph20)	Hyaluronidase	[3] D04455, D04456, D06604 💬	-	-	[1] 65 💬
2	Daratumumab co-formulated with recombinant human hyaluronidase (rhuph20)	Daratumumab	[4] D04455, D04456, D06604, D10777 💬	[1] CD38 💬	[7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion	[1] 28 💬
3	Recombinant human hyaluronidase (rhuph20)	Hyaluronidase	[3] D04455, D04456, D06604 💬	-	-	[1] 65 💬
4	Recombinant human hyaluronidase (rhuph20)+ immune globulin intravenous (igiv)	Hyaluronidase	[3] D04455, D04456, D06604 💬	-	-	[1] 65 💬
5	Rhuph20	-	-	-	-	[2] 13, 14 💬
6	Sc treatment with igsc, 10% with rhuph20 followed by iv/igsc, 10% only (safety)	-	-	-	-	[1] 65 💬
7	Sc treatment with igsc, 10% with rhuph20 followed by sc/igsc, 10% only (safety)	-	-	-	-	[1] 65 💬